ArticleACR open rheumatology2025
Using a Mental Health Care Navigator to Overcome Barriers to Care in Childhood-Onset Systemic Lupus Erythematosus.
Article in ACR open rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveMental health (MH) disorders are common in childhood-onset systemic lupus erythematosus (cSLE), yet MH care use in this population is low. We developed an MH care navigator program at our institution to address barriers to MH care in cSLE. Here, we describe findings from the program.
methodsWe performed descriptive analysis of patients with cSLE in our program, including demographics, anxiety and depression screening results, MH diagnoses, and MH referrals.
resultsAll patients with cSLE at our institution were included (N = 79). The mean age at program start was 16 years, 81% of patients were female, and 32% were Asian. At least one validated depression and anxiety screening was completed in 70 (88%) and 68 (86%) patients, respectively. Of those screened, 16 (24%) had moderate or higher scores for depression and 21 (32%) had moderate or higher scores for anxiety. Twenty-four (30%) patients received new MH services after the program started, with 75% of those having previously accessed MH services. Neuropsychologic testing was completed in 37% (7 of 19) of patients diagnosed after program start, versus 25% (15 of 60) of those diagnosed before the program.
conclusionMH disease is common in cSLE, yet access to MH care is inadequate. Over one-quarter of our patients screened in the moderate or higher range for depression or anxiety. Our MH care navigator facilitated both screening and comprehensive psychosocial assessment, leading to timely and appropriate referrals. This model may improve care for patients with cSLE and could be replicated in other pediatric rheumatology programs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.